Fostamatinib Disodium Hexahydrate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Fostamatinib Disodium Hexahydrate
US Patents

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Fostamatinib Disodium Hexahydrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 1 USDMF, 1 JDMF, 2 NDC API, $ API Reference Price

2 API Suppliers
1 USDMF
1 JDMF
2 NDC API
$ API Reference Price

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

2 FDF Dossiers
2 FDA Orange Book

DIGITAL CONTENT

17 NEWS #PharmaBuzz

17 NEWS #PharmaBuzz

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

28 US Patents, 2 US Exclusivities

28 US Patents
2 US Exclusivities

$ API Ref.Price (USD/KG) : 19,619 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

28 All

01 28RIGEL PHARMS

filter Patent Number Reset all filters

28 All

01 27449458

02 27538108

03 27989448

04 28163902

05 28211889

06 28263122

07 28445485

08 28652492

09 28771648

10 28912170

11 28951504

12 29266912

13 29283238

14 2RE48898

filter API Patent Reset all filters

28 All

01 10Y

02 18Blank

filter FDF Patent Reset all filters

28 All

01 10Y

02 18Blank

filter Expiration Date Reset all filters

28 All

01 62026-01-19

02 22026-03-28

03 22026-06-12

04 82026-06-17

05 22028-11-06

06 22030-11-24

07 22031-09-04

08 42032-07-27

Product Main Page

01

RIGEL PHARMS

FOSTAMATINIB DISODIUM

Fi Europe 2024

Not Confirmed

RIGEL PHARMS

Country

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-06-17

FOSTAMATINIB DISODIUM

US Patent Number : 9283238

Drug Substance Claim :

Drug Product Claim :

Application Number : 209299

Patent Use Code : U-2294

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

RIGEL PHARMS

FOSTAMATINIB DISODIUM

Fi Europe 2024

Not Confirmed

RIGEL PHARMS

Country

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-06-12

FOSTAMATINIB DISODIUM

US Patent Number : 7989448

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 209299

Patent Use Code : U-2294

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

RIGEL PHARMS

FOSTAMATINIB DISODIUM

Fi Europe 2024

Not Confirmed

RIGEL PHARMS

Country

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-01-19

FOSTAMATINIB DISODIUM

US Patent Number : 9266912

Drug Substance Claim :

Drug Product Claim :

Application Number : 209299

Patent Use Code : U-2294

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-19

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

RIGEL PHARMS

FOSTAMATINIB DISODIUM

Fi Europe 2024

Not Confirmed

RIGEL PHARMS

Country

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-06-17

FOSTAMATINIB DISODIUM

US Patent Number : 9283238

Drug Substance Claim :

Drug Product Claim :

Application Number : 209299

Patent Use Code : U-2294

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

RIGEL PHARMS

FOSTAMATINIB DISODIUM

Fi Europe 2024

Not Confirmed

RIGEL PHARMS

Country

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-07-27

FOSTAMATINIB DISODIUM

US Patent Number : 8951504

Drug Substance Claim :

Drug Product Claim :

Application Number : 209299

Patent Use Code : U-2294

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-07-27

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

RIGEL PHARMS

FOSTAMATINIB DISODIUM

Fi Europe 2024

Not Confirmed

RIGEL PHARMS

Country

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-06-17

FOSTAMATINIB DISODIUM

US Patent Number : 8912170

Drug Substance Claim :

Drug Product Claim :

Application Number : 209299

Patent Use Code : U-2294

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

RIGEL PHARMS

FOSTAMATINIB DISODIUM

Fi Europe 2024

Not Confirmed

RIGEL PHARMS

Country

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-03-28

FOSTAMATINIB DISODIUM

US Patent Number : 7538108

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 209299

Patent Use Code : U-2294

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

RIGEL PHARMS

FOSTAMATINIB DISODIUM

Fi Europe 2024

Not Confirmed

RIGEL PHARMS

Country

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-03-28

FOSTAMATINIB DISODIUM

US Patent Number : 7538108

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 209299

Patent Use Code : U-2294

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-28

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

RIGEL PHARMS

FOSTAMATINIB DISODIUM

Fi Europe 2024

Not Confirmed

RIGEL PHARMS

Country

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-07-27

FOSTAMATINIB DISODIUM

US Patent Number : 8951504

Drug Substance Claim :

Drug Product Claim :

Application Number : 209299

Patent Use Code : U-2294

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-07-27

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

RIGEL PHARMS

FOSTAMATINIB DISODIUM

Fi Europe 2024

Not Confirmed

RIGEL PHARMS

Country

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-06-17

FOSTAMATINIB DISODIUM

US Patent Number : 8163902

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 209299

Patent Use Code : U-2294

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?